chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fatigue; Headache; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration at Left arm on 30Jan2021 17:45 at single dose for covid-19 immunization. Medical history included allergies. The patient had allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were yes but unspecified. The patient received other medications within 2 weeks of vaccination. The patient experienced chills, fatigue and headache, all on 30Jan2021 19:30. Since the vaccination, the patient had not been tested for COVID-19. The outcome was unknown. The seriousness from reporter was non-serious.
Muscle aches and rash, diagnosed as shingles via Dr, prescribed valacyclovir 1gm tablets
Bronchitis; Cough; This case was reported by a physician via call center representative and described the occurrence of bronchitis in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   In December 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, 4 days after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced bronchitis and cough. On an unknown date, the outcome of the bronchitis and cough were not recovered/not resolved.   It was unknown if the reporter considered the bronchitis and cough to be related to Shingrix.  Additional details were reported as follows: In mid October 2019, the patient received 1st dose of Shingrix. The patient received Shingrix approximately one week ago prior to reporting and around four days after receiving the vaccine, he developed bronchitis and describes that she has been coughing. Reporter did not consent to follow-up. This case has been linked with another case US2020000938, reported by same reporter.
felt pretty horrible; unable to work; developed induration at the site of injection.; developed allergic sort of reaction at the site of injection.; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (felt pretty horrible), DECREASED ACTIVITY (unable to work), INJECTION SITE INDURATION (developed induration at the site of injection.) and INJECTION SITE REACTION (developed allergic sort of reaction at the site of injection.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced INJECTION SITE INDURATION (developed induration at the site of injection.) and INJECTION SITE REACTION (developed allergic sort of reaction at the site of injection.). On an unknown date, the patient experienced FEELING ABNORMAL (felt pretty horrible) and DECREASED ACTIVITY (unable to work). At the time of the report, FEELING ABNORMAL (felt pretty horrible), DECREASED ACTIVITY (unable to work), INJECTION SITE INDURATION (developed induration at the site of injection.) and INJECTION SITE REACTION (developed allergic sort of reaction at the site of injection.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter.  No treatment information was provided.    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included blood clots in her leg. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported. On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Patient filled out VAR to receive Flu and Covid booster, Verified vaccines with patient, she said yes. When documenting both vaccines, a hard stop popped up stating she had already received her flu vaccine in October of 2021. No adverse reactions, but patient received an extra dose of the flu vaccine.
Soreness has moved from right arm to the to right side of the back; Soreness has moved from right arm to the to right side of the breast/Front side of the breast aches; Rash on the right side of the back/Rash on the right side of the breast; Soreness in right arm at the injection site after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness in right arm at the injection site after the second dose), BACK PAIN (Soreness has moved from right arm to the to right side of the back), BREAST PAIN (Soreness has moved from right arm to the to right side of the breast/Front side of the breast aches) and RASH (Rash on the right side of the back/Rash on the right side of the breast) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced INJECTION SITE PAIN (Soreness in right arm at the injection site after the second dose). On 31-Mar-2021, the patient experienced BACK PAIN (Soreness has moved from right arm to the to right side of the back), BREAST PAIN (Soreness has moved from right arm to the to right side of the breast/Front side of the breast aches) and RASH (Rash on the right side of the back/Rash on the right side of the breast). At the time of the report, INJECTION SITE PAIN (Soreness in right arm at the injection site after the second dose), BACK PAIN (Soreness has moved from right arm to the to right side of the back), BREAST PAIN (Soreness has moved from right arm to the to right side of the breast/Front side of the breast aches) and RASH (Rash on the right side of the back/Rash on the right side of the breast) outcome was unknown.
Information has been received from a pharmacist concerning a retired female pt who in 1983 and 1990 was vaccinated with the 1st and 2nd doses of MMR. On about 12/14/99, the pt was tested for antibodies and shown to be negative. She sought unspecified medical attention. No further information is available.
Information has been received from a physician concerning her approximately 1 year old daughter who on an unspecified date was vaccinated in her thigh with a first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck update process). Concomitant vaccination included a dose of hepatitis A vaccine (inactive) (MSD).  Subsequently, the patient developed a fever, a measles-like rash and her hands swelled.  The patient had a follow-up visit with her treating physician.  The patient's mother did take pictures of the patient's condition. The patient recovered 4-5 days later. No further information was provided.  There was no product quality complaint involved.  Additional information has been requested.
No adverse effect reported; patient was inadvertently administered a second dose of PNEUMOVAX 23; Information has been received from a physician referring to a 68 years old patient of unknown gender. The patient's concomitant medications, pertinent medical history and drug/ allergies reactions were not provided.  The patient was administered a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot number and expiration date, frequency and route were not provided) for prophylaxis in May 2018. On 11-JUN-2019, the patient was inadvertently administered a second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot R027298, expiration date 09-APR-2020, route was intramuscular) instead of an intended dose of pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) (lot number and expiration date, frequency, indication and route were not provided). The physician reported the error occurred because he mistakenly thought the patient had already received pneumococcal 13v conj vaccine (crm197) (PREVNAR 13), then after the dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered, he discovered that the patient had already previously received pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (wrong product administered). No adverse effect was reported.
Patient reports hives, muscle spasms, fatigue, and "brain fog" beginning 8/13/21.  Symptoms had not resolved by 8/17/21, so she was seen by her PCP on 8/17/21.  Currently on Prednisone (unsure of dosage) and Flexiril prescribed by PCP.  Has follow up appointment 8/23/21
Pt recv vax on 9/22/98; on same day pt exp fever (104), rash on chest &back; seen by M.D. 9/24; dx adverse rx to pertussis.
Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: pt reported sweating, gave him tylenol, and a glass of water
At first only moderate arm pain and soreness, fatigue and nausea and headache lasting 24 hours. Then two weeks of being totally fine. Then suddenly woke up on the 14th day feeling like I had been shot in the arm by a gun. Limited mobility in arm and shoulder, extreme pain at injection side and in shoulder. Range of motion that hurts feels similar to rotator cuff injury (which I?ve had before and therefore can identify.) The two weeks in between there were no symptoms. I don?t know if these are related, but just in case- I also woke up with a headache and rib pain on my right side. My elbow on injection site side now feels painful but I do have pain there sometimes anyway. Soreness from shoulder down to wrist. I am a bartender and had to go home early from work due to the pain. I am concerned this will not go away. Could it be SIRVA? Could SIRVA suddenly show up two weeks *after* an injection? Thank you.
Developed upper respiratory infection On 7/2/2021. Low grade fever, cough, chest congestion, sore throat,  yellow mucus,  difficulty breathing, phlegm
shingles; This is a spontaneous report from a contactable Consumer. A 59-years-old patient of unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8729, expiry date: unknown) via unspecified route of administration, in left arm on 12Apr2021 09:00 (age at vaccination: 59), as dose 1, single for covid-19 immunisation. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0172, expiry date: unknown) via unspecified route of administration, in left arm on 05May2021 09:00 (age at vaccination: 59), as dose 2, single for covid-19 immunisation. Vaccination facility type was school/student health clinic. No prior vaccinations (within 4 weeks) taken within four weeks prior to the first administration date of the suspect vaccine. Medical history included high blood pressure from an unspecified date and unknown if ongoing. Concomitant medication included ongoing Valsartan (pill), start date unknown, taken for high blood pressure. On 15Apr2021, patient experienced herpes zoster. Emergency room visit took place due to the adverse event. Treatment regimen was provided as a result of the adverse event. Patient underwent lab test which included biopsy test on 19Apr2021 with positive result (shingles). The outcome of event was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Nausea, throwing up (for 6 hours), dizzy, no fever, injection sight started to hurt Spoke with Drs office - Bed rest, liquids and Zofran  (treated like a stomach virus) Drs office suggested I fill out this form since I had same symptoms exactly one week after first dose of vaccine
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 20-DEC-2018, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372:
6-14-13 at 0800 patient noticed small red knot on back of left arm, painless to touch. Throughout the course of the day the knot enlarged and at 16:00 knot was size of an egg and decided to notify Health Dept at 16:00.
I had all the symptoms of the flu, plus loss of taste and smell.   Symptoms began 12/26/2021, and lasted 1 week.   Smell came back within the first week.  Taste came back 10 days later.
Starting the day after my first vaccination, I experienced noticeable swelling around the injection site, roughly the size of a playing card. As of today it has been 8 days and the swelling has only slightly subsided. It is sore and very itchy and warm upon touch.
Received flumist at 3:45pm, immediately followed by flushed face and warm ears, at 5:00 pm developed chills & sleepness, hives developed at 12:30 pm on 11/1, took 25 mg of Benadryl, no other problems.  Client has had injectable flu vaccines in the past with no reactions.
Pharmacist did not mix the diluent with the active powder of the vaccine and injected only the diluent. No know adverse events have been reported by the patient or his guardians, we have called the patient to notify them of the error but have not heard back from them yet.
vaccination site pain; vaccination site swelling; vaccination site erythema; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site erythema) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site erythema). At the time of the report, VACCINATION SITE PAIN (vaccination site pain), VACCINATION SITE SWELLING (vaccination site swelling) and VACCINATION SITE ERYTHEMA (vaccination site erythema) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.
no adverse effects; a 68 year old patient received a dose of PROQUAD; This spontaneous report was received from a nurse regarding a 68 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 26-APR-2018, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, exact dose, route of administration, lot number and expiration date were not reported) for prophylaxis during an office visit (product administered to patient of inappropriate age). No adverse effects were reported. No product quality complaints were involved.
Superficial thrombophlebitis, itching around mouth, eyes, and joints, breathing difficulties - administered cetirizine HCl 10mg antihistamine at onset of symptoms and 2 puffs Albuterol Sulfate HFA Inhalation Aerosol 90mcg per actuation approx 90 minutes after onset to control symptoms until they fully subsided.
Severe Abdominal Pain and skin rash in face, neck, chest and left arm for over ten days.  Other symptoms: lack of taste, muscle pains in lower extremities/back/arm, ringing ear, itching, throat narrowing/shortness of breath, weight loss, extreme fatigue and weakness for several days; brain fog, dizziness, difficulty swallowing/sleeping.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: patient came into the pharmacy and stated that she have adverse reactions (rashes,swelling and pruritus) from the 3rd COVID shot administered on 09/01/2021.
Painful and itchy red rash at injection site began 8 days after injection. Took Benadryl as advised.
Fainting; Back pain; she was little warm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 16-year-old female patient received BNT162b2 (BNT162B2), on 04Jun2022 as dose number unknown (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: SYNCOPE (medically significant), outcome "unknown", described as "Fainting"; BACK PAIN (non-serious), outcome "unknown"; FEELING HOT (non-serious), outcome "unknown", described as "she was little warm".  Clinical Information:Reporter stated, Yes, I think it's a question and a record actually.Before, yesterday she had the boost for COVID Vaccine. So, Yesterday she felt like fainting, fainted and we brought her home she slept, she was little warm but today she is complaining a lot of back pain.When paraphrased the concern: Reporter stated, Yes, she got her booster the day before yesterday.Other Concomitant Medication: Reporter stated, No. She take multi vitamin. She was taking it for extra medication but she is not taking it right now.No treatment was received for adverse event.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt recvd vax & became very ill; pt went to hosp & was treated w/med; MD felt pt had flu;
Onset 5 days after the shot with a headache- I took one ALEVE tablet- Headache continued along with sweats, nausea, vomiting, diarrhea. Slept through the night after vomiting and awoke free of all symptoms (shot 9-22-16) (Flu symptoms 9-27-16).
12 days after vaccine experienced closing of throat; difficulty breathing; vocal chord dysfunction; excessive congestions; sore throat; cough; bloody noses; fatigue. Went to urgent care and confirmed negative Covid-19 and negative strep test. Saw campus clinician on May-24 and determined "just allergies." Saw primary physician on May-17 . Also confirmed allergies but severity of symptoms not typical for patient who has been on immunotherapy for years  for seasonal allergies.. Initiated aggressive allergy treatment with medications and when symptoms got worse instead of better wad finally put on oral steroids. And then also required a course of antibiotics. Illness lasted almost 3 weeks.
swelling and redness to injection site. Hives to neck. Pt reports of sore throat limited to the side of the injection.
began having brown vaginal discharge. I'm unsure if this is the start of her first menstrual cycle. SHe has never had any vaginal discharge before.
Post vax, the pt developed a 2 1/2 x 2 1/2 inch area of redness, raised with edema, and hot to the touch.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 60-year-old female patient who received SHINGRIX (batch number 353S5, expiry date 29th May 2021) for prophylaxis. On 21st March 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In March 2019, less than a week after receiving SHINGRIX, the patient experienced injection site erythema and injection site warmth. The patient was treated with Cream (Nos). On an unknown date, the outcome of the injection site erythema and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on right arm. The patient experienced redness and warmth at the injection site covering size of 6 inches by 6 inches approximately the size of softball. The patient used rattlesnake cream and the redness and warmth went away. No further details were provided.
Severe bruising 3 in below inj site to elbow extended to 8 in on (L) arm. Rx - KEFLEX 500 mg qid x7 days.